Michels S - Search Results

1

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS. Moshfeghi AA, et al. Among authors: michels s. Ophthalmology. 2006 Nov;113(11):2002.e1-12. doi: 10.1016/j.ophtha.2006.05.070. Epub 2006 Oct 5. Ophthalmology. 2006. PMID: 17027972 Clinical Trial.

2

Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results.

Schmidt-Erfurth UM, Michels S, Kusserow C, Jurklies B, Augustin AJ. Schmidt-Erfurth UM, et al. Among authors: michels s. Ophthalmology. 2002 Dec;109(12):2284-94. doi: 10.1016/s0161-6420(02)01454-9. Ophthalmology. 2002. PMID: 12466172

3

Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.

Schmidt-Erfurth UM, Michels S. Schmidt-Erfurth UM, et al. Among authors: michels s. Ophthalmology. 2003 Jul;110(7):1306-14. doi: 10.1016/S0161-6420(03)00452-4. Ophthalmology. 2003. PMID: 12867383 Clinical Trial.

4

Effects of verteporfin therapy on central visual field function.

Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, Michels SM. Schmidt-Erfurth UM, et al. Ophthalmology. 2004 May;111(5):931-9. doi: 10.1016/j.ophtha.2003.12.025. Ophthalmology. 2004. PMID: 15121371 Clinical Trial.

5

Photodynamic therapy with verteporfin: a new treatment in ophthalmology.

Michels S, Schmidt-Erfurth U. Michels S, et al. Semin Ophthalmol. 2001 Dec;16(4):201-6. doi: 10.1076/soph.16.4.201.10298. Semin Ophthalmol. 2001. PMID: 15513441 Review.

6

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Michels S, et al. Ophthalmology. 2005 Jun;112(6):1035-47. doi: 10.1016/j.ophtha.2005.02.007. Ophthalmology. 2005. PMID: 15936441 Clinical Trial.

7

[Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis].

Michels S, Rosenfeld PJ. Michels S, et al. Klin Monbl Augenheilkd. 2005 Jun;222(6):480-4. doi: 10.1055/s-2005-858315. Klin Monbl Augenheilkd. 2005. PMID: 15973626 Review. German.

8

Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Schmidt-Erfurth U, Michels S, Michels R, Aue A. Schmidt-Erfurth U, et al. Among authors: michels r, michels s. Eur J Ophthalmol. 2005 Jul-Aug;15(4):482-5. doi: 10.1177/112067210501500411. Eur J Ophthalmol. 2005. PMID: 16001382 Clinical Trial.

9

Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.

Michels S, Wachtlin J, Gamulescu MA, Heimann H, Prünte C, Inhoffen W, Krebs I, Schmidt-Erfurth U. Michels S, et al. Ophthalmology. 2005 Dec;112(12):2070-5. doi: 10.1016/j.ophtha.2005.06.034. Epub 2005 Oct 12. Ophthalmology. 2005. PMID: 16225928 Clinical Trial.

10

Time course and morphology of vascular effects associated with photodynamic therapy.

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S. Schmidt-Erfurth U, et al. Among authors: michels s. Ophthalmology. 2005 Dec;112(12):2061-9. doi: 10.1016/j.ophtha.2005.09.007. Ophthalmology. 2005. PMID: 16325705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters